New guidelines for gender equity in science

Monday, 11 March, 2013

The Early/Mid Career Researcher Forum of the Australian Academy of Science published on Friday working guidelines to ensure that women and men have equal opportunities to pursue a successful career in science.

Endorsed by the Council of the Academy, ‘Gender equity: current issues, best practice and new ideas’ describes current issues and presents 15 practical initiatives to ensure gender equity at work, including:

  • Flexible work hours
  • Provision of parenting rooms
  • Initiatives to support and promote the inclusion of women at national and international conferences and meetings
  • Active mentoring for women scientists
  • Female representation on committees

Designed to be used by universities, research institutes and laboratories across Australia, it also proposes suggestions provided by women currently working in research at an early- or mid-career stage.

Academy President Professor Suzanne Cory said it was “highly appropriate” that the forum released the guidance on International Women’s Day.

“The implementation of these suggestions would help to ensure women can thrive in careers in science. We hope they will be implemented in every Australian research organisation to enable women to achieve success in the competitive research workplace,” she said.

“Some of the suggestions, such as ensuring meetings are held during family-friendly hours, will not cost money but make a big difference.”

Forum Chair Dr Maggie Evans-Galea said the document is intended to be a handbook in all Australian research organisations.

“The forum wants to see current best practices become the norm across all research organisations,” Dr Evans-Galea said.

The document is available at www.science.org.au/policy/documents/GenderEquityEMCRForum.pdf.

Related News

Australian Academy of Science 2027 honorific awards — nominations close 1 May

Recognising outstanding contributions to the advancement of science, nominations for the Academy...

QIMR Berghofer signs strategic partnership with Nakanoshima Qross

QIMR Berghofer and Japanese biomedical innovation hub Nakanoshima Qross have signed a strategic...

Dr Chris Baldwin is new HaemaLogiX CEO and Managing Director

Having commenced in January, Dr Chris Baldwin is clinical stage Australian biotechnology company...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd